Musings on guidelines and evidence: An opposing view

Peritoneal Dialysis International

Volumn 27, Issue 1, 2007, Pages 35-38

  Suri, Rita S ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CLINICAL PRACTICE; CONTINUOUS HEMODIALYSIS; DRUG INDUSTRY; EVIDENCE BASED MEDICINE; FUNDING; HUMAN; MEDICAL CARE; MEDICAL PRACTICE; MEDICAL RESEARCH; MEDICAL SOCIETY; MORTALITY; NEPHROLOGY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; RISK REDUCTION; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; METHODOLOGY; NOTE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; STANDARD;

HUMANS; KIDNEY FAILURE, CHRONIC; NEPHROLOGY; PRACTICE GUIDELINES; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RENAL DIALYSIS;

EID: 33947119608     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080702700107     Document Type: Article

References (13)

1. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010-19.
2. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized controlled trial. J Am Soc Nephrol 2002; 13:1307-20.
3. Held PJ, Levin NW, Bovbjerg RR, Pauly MV, Diamond LH. Mortality and duration of hemodialysis treatment. JAMA 1991; 265:871-5.
4. Hakim RM, Breyer J, Ismail N, Schulman G. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994; 23:661-9.
5. Bloembergen WE, Stannard DC, Port FK, Wolfe RA, Pugh JA, Jones CA, et al. Relationship of dose of hemodialysis and cause-specific mortality. Kidney Int 1996; 50:557-65.
6. Churchill DN. Outcome studies in adequacy of dialysis. Perit Dial Int 1997; 17(Suppl 3):S42-5.
7. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative Randomized Controlled Trial. JAMA 2004; 291:1701-12.
8. Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ, et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 2002; 288:2432-40.
9. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324: 781-8.
10. Reddan DN, Szczech LA, Hasselblad V, Lowrie EG, Lindsay RM, Himmelfarb J, et al. Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J Am Soc Nephrol 2005; 16:2162-9.
11. Sinclair JC, Cook RJ, Guyatt GH, Pauker SG, Cook DJ. When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment. J Clin Epidemiol 2001; 54:253-62.
12. Strippoli GF, Craig JC, Schena FP. The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol 2004; 15:411-19.
13. Genzyme Corporation. Genzyme announces positive results from DCOR trial favouring use of Renagel. Available at: http://www.renagel.com/docs/ DCOR_07_28_05.pdf. Last accessed: 15 October 2006.